Prity Khastgir

Prity Khastgir

Patent attorney with expertise in IP portfolio management, cross-border technology transactions, licensing agreements, due diligence analyses, product clearance, freedom-to-operate, infringement, and validity (Patent Invalidation) analysis, research and opinions. Core practice includes patent drafting, patent searches (patent analytics) & patent prosecution (drafting office action responses for USPTO, EPO, UKIPO etc.)

Special technical expertise in the fields of biotechnology, pharmaceuticals, molecular biology, biochemistry, microbiology, biosimilars, medical devices, immunology and healthcare.

Go-to patent consultant for all time zones, be it new product launch in Asia, IP landscape across EU, freedom-to-operate analysis in Japan or patent invalidation for litigation in US.

Senior executive profile with featured publications: BBC World, Nature Group (Nature Reviews Drug Discovery), BioSpectrum Asia etc.

Previous work experience with US Law Firm headquartered in Greater New York City Area.

First hand exposure to international patent procedures.

Directly trained by senior US & EP patent attorneys.

Engagement models: hourly, project based, contractual consulting & monthly retainer.

Have successfully executed projects on behalf of clients of every size in domain of pharmaceuticals, drug-eluting stents, chemistry, diagnostic assays, computational biology, cosmetics, vaccines, antibodies, food products, enzymes, neurology and cancer therapy.

Related practice areas include general business counseling, legal advice, legal service, drug discovery, drug development, project management and intersection of intellectual property with competition laws, drug regulations, generic drug policies, innovation management, market-entry strategy and competitive intelligence.

Full Profile: